Principal Investigator
Rebecca B Price, PhD
University of Pittsburgh
- 2 trials
- 1 recruiting now
- 1 compound
Therapeutic focus
- Major Depressive Disorder
- Suicide, Attempted
Recruiting now (1)
| NCT | Phase | Status | Compound | Sponsor |
|---|---|---|---|---|
| NCT06400121 | Phase 2 | Recruiting | Apimostinel (GATE-202) | Syndeio Biosciences, Inc. |
All trials (2)
| NCT | Phase | Status | Compound | Sponsor |
|---|---|---|---|---|
| NCT06400121 | Phase 2 | Recruiting | Apimostinel (GATE-202) | Syndeio Biosciences, Inc. |
| NCT04578938 | Phase 4 | Active | — | Rebecca Price |
Compounds studied
Trial sites (1)
- Pittsburgh, Pennsylvania, United States
Investigator and site data mirrored fromClinicalTrials.gov (public domain).